Importantly, HMGB3 is an oncogene that promotes tumor occurrence, development, and chemotherapy resistance, through a variety of mechanisms, in breast cancer [12], colorectal cancer [13], thyroid cancer [14], neuroblastoma [15], nasopharyngeal carcinoma [16], and cervical cancer [17]. This evidence concerns the gene HMGB3 and colorectal cancer.